First People's Hospital of Jingzhou

Institution (Healthcare)

Homepage ROR

Also Known As

First People's Hospital of Jingzhou

1.6K

Publications

37.4K

Citations

125

Authors

334

Concepts

About

First People's Hospital of Jingzhou is a healthcare institution in Jingzhou, China known for medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	258	9.5K
2	Engineering	17	24	1.2K
3	Health Sciences	13	46	848
4	Public Health	12	22	3.4K
5	Natural Sciences	5	11	268

First People's Hospital of Jingzhou

1.6K

Publications

37.4K

Citations

Page 1

	Year	Citations
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes Lihua Zhu, Zhi‐Gang She, Xu Cheng, Cell Metabolism Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyHealth PolicyGlobal Health	2020	1.6K
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province Kui Liu, Yuan-Yuan Fang, Yan Deng, Chinese Medical Journal	2020	1.5K
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial Wei Tang, Zhujun Cao, Mingfeng Han, BMJ	2020	1.1K
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 Xiao-Jing Zhang, Juan‐Juan Qin, Xu Cheng, Cell Metabolism Reduced RiskPreventive MedicineLong CovidGlobal HealthCovid-19 Pandemic	2020	492
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China Xin Xu, Jian Sun, Sheng Nie, Nature Medicine VaccinationViral DiagnosticsVaccine TargetImmunologySerologic Testing	2020	450
Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China Fang Zheng, Chun Liao, Qi-hong Fan, Current Medical Science	2020	425
Fracture detection in pediatric wrist trauma X-ray images using YOLOv8 algorithm Rui‐Yang Ju, Weiming Cai Scientific Reports	2023	206
Hydroxychloroquine in patients mainly with mild to moderate COVID–19: an open–label, randomized, controlled trial Wei Tang, Zhujun Cao, Mingfeng Han, PharmacotherapyHcq RecipientsCovid-19Clinical EpidemiologyClinical Trials	2020	197
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12 Yongyong Shi, Li Li, Zhibin Hu, Nature Genetics Genome-wide Association StudyCervical CancerCervical HealthGeneticsGenetic Epidemiology	2013	148
A genome-wide association study identifies six novel risk loci for primary biliary cholangitis Fang Qiu, Ruqi Tang, Xianbo Zuo, Nature Communications	2017	147

Page 1